Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Breast Cancer

  Free Subscription


Articles published in J Natl Cancer Inst

Retrieve available abstracts of 104 articles:
HTML format
Text format



Single Articles


    October 2017
  1. VISSCHER DW, Frank RD, Carter JM, Vierkant RA, et al
    Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available



  2. Restarting Adjuvant Hormone Therapy Improves Breast Cancer Outcomes.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  3. HE W, Smedby KE, Fang F, Olsson H, et al
    Treatment Restarting After Discontinuation of Adjuvant Hormone Therapy in Breast Cancer Patients.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    September 2017
  4. BYRNE C, Ursin G, Martin CF, Peck JD, et al
    Mammographic Density Change With Estrogen and Progestin Therapy and Breast Cancer Risk.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    August 2017
  5. POLLACK CE, Soulos PR, Herrin J, Xu X, et al
    The Impact of Social Contagion on Physician Adoption of Advanced Imaging Tests in Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  6. SCHMIDT MK, van den Broek AJ, Tollenaar RA, Smit VT, et al
    Breast Cancer Survival of BRCA1/BRCA2 Mutation Carriers in a Hospital-Based Cohort of Young Women.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  7. GINGRAS I, Holmes E, De Azambuja E, Nguyen DH, et al
    Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    July 2017
  8. SHAFAEE MN, Ellis MJ
    Breast Cancer Patient-Derived Xenografts: Pros, Cons, and Next Steps.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  9. WU X, Ye Y, Barcenas CH, Chow WH, et al
    Personalized Prognostic Prediction Models for Breast Cancer Recurrence and Survival Incorporating Multidimensional Data.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  10. ROJAS PA, May M, Sequeira GR, Elia A, et al
    Progesterone Receptor Isoform Ratio: A Breast Cancer Prognostic and Predictive Factor for Antiprogestin Responsiveness.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  11. GOETZ MP, Kalari KR, Suman VJ, Moyer AM, et al
    Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    June 2017
  12. SAMANTA SK, Sehrawat A, Kim SH, Hahm ER, et al
    Disease Subtype-Independent Biomarkers of Breast Cancer Chemoprevention by the Ayurvedic Medicine Phytochemical Withaferin A.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  13. DAVE B, Gonzalez DD, Liu ZB, Li X, et al
    Role of RPL39 in Metaplastic Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available



  14. Higher consumption of grilled, barbecued, and smoked meat linked to increased mortality risk among breast cancer survivors.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    May 2017
  15. KERLIKOWSKE K, Gard CC, Tice JA, Ziv E, et al
    Risk Factors That Increase Risk of Estrogen Receptor-Positive and -Negative Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  16. WALTER JR, Xu S, Woodruff TK
    A Call for Fertility Preservation Coverage for Breast Cancer Patients: The Cost of Consistency.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


    April 2017
  17. NOLAN E, Vaillant F, Visvader JE, Lindeman GJ, et al
    RE: Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2017 Apr 4. doi: 10.1093.
    PubMed     Text format    


  18. SCHERNHAMMER ES
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  19. HANSEN J
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  20. ERREN TC, Morfeld P, Gross JV
    RE: Night Shiftwork and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  21. STEVENS RG
    RE: Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  22. GARRIDO-CASTRO AC, Winer EP
    Genomic Profiling in Node-Positive ER-Positive Early Breast Cancer: Can Tumor Biology Guide Locoregional Therapy?
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


    March 2017
  23. MA R, Karthik GM, Lovrot J, Haglund F, et al
    Estrogen Receptor beta as a Therapeutic Target in Breast Cancer Stem Cells.
    J Natl Cancer Inst. 2017;109:1-14.
    PubMed     Text format     Abstract available


    February 2017
  24. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  25. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  26. BANEGAS MP, John EM, Slattery ML, Gomez SL, et al
    Projecting Individualized Absolute Invasive Breast Cancer Risk in US Hispanic Women.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  27. SINDZINSKI A
    Risk of Heart Disease in Breast Cancer Patients Receiving Estrogen-Deprivation Therapy.
    J Natl Cancer Inst. 2017;109:2-3.
    PubMed     Text format    


  28. GREENLEE H, Hershman DL, Shi Z, Kwan ML, et al
    BMI, Lifestyle Factors and Taxane-Induced Neuropathy in Breast Cancer Patients: The Pathways Study.
    J Natl Cancer Inst. 2017;109:1-8.
    PubMed     Text format     Abstract available


  29. ERIKSEN KT, McElroy JA, Harrington JM, Levine KE, et al
    Urinary Cadmium and Breast Cancer: A Prospective Danish Cohort Study.
    J Natl Cancer Inst. 2017;109:1-7.
    PubMed     Text format     Abstract available


    January 2017
  30. PARADA H JR, Steck SE, Bradshaw PT, Engel LS, et al
    Grilled, Barbecued, and Smoked Meat Intake and Survival Following Breast Cancer.
    J Natl Cancer Inst. 2017 Jan 4. pii: djw299. doi: 10.1093.
    PubMed     Text format     Abstract available


  31. KOTSOPOULOS J, Huzarski T, Gronwald J, Singer CF, et al
    Bilateral Oophorectomy and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  32. HILAKIVI-CLARKE L, Warri A, Bouker KB, Zhang X, et al
    Effects of In Utero Exposure to Ethinyl Estradiol on Tamoxifen Resistance and Breast Cancer Recurrence in a Preclinical Model.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  33. SMITH BD, Jiang J, Shih YC, Giordano SH, et al
    Cost and Complications of Local Therapies for Early-Stage Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  34. PARKES EE, Walker SM, Taggart LE, McCabe N, et al
    Activation of STING-Dependent Innate Immune Signaling By S-Phase-Specific DNA Damage in Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  35. BENSE RD, Sotiriou C, Piccart-Gebhart MJ, Haanen JB, et al
    Relevance of Tumor-Infiltrating Immune Cell Composition and Functionality for Disease Outcome in Breast Cancer.
    J Natl Cancer Inst. 2016;109.
    PubMed     Text format     Abstract available


  36. MAMOUNAS EP, Liu Q, Paik S, Baehner FL, et al
    21-Gene Recurrence Score and Locoregional Recurrence in Node-Positive/ER-Positive Breast Cancer Treated With Chemo-Endocrine Therapy.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available


  37. HAAS JS
    The Complexity of Achieving the Promise of Precision Breast Cancer Screening.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format    


  38. SHIEH Y, Eklund M, Madlensky L, Sawyer SD, et al
    Breast Cancer Screening in the Precision Medicine Era: Risk-Based Screening in a Population-Based Trial.
    J Natl Cancer Inst. 2017;109.
    PubMed     Text format     Abstract available



  39. Different Breast Cancer Treatment Options Vary Widely in their Cost-Effectiveness.
    J Natl Cancer Inst. 2017;109:1-2.
    PubMed     Text format    


    December 2016
  40. TRAVIS RC, Balkwill A, Fensom GK, Appleby PN, et al
    Night Shift Work and Breast Cancer Incidence: Three Prospective Studies and Meta-analysis of Published Studies.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available



  41. Night Shift Work and Breast Cancer Risk.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    November 2016
  42. TER BRUGGE P, Kristel P, van der Burg E, Boon U, et al
    Mechanisms of Therapy Resistance in Patient-Derived Xenograft Models of BRCA1-Deficient Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  43. VISVANATHAN K, Yager JD
    Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    October 2016
  44. MOORE SC, Matthews CE, Ou Shu X, Yu K, et al
    Endogenous Estrogens, Estrogen Metabolites, and Breast Cancer Risk in Postmenopausal Chinese Women.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  45. VISVANATHAN K, Yager JD
    Ethnic Variations in Estrogen and Its Metabolites: Sufficient to Explain Differences in Breast Cancer Incidence Rates?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    September 2016
  46. NATRAJAN R, Weigelt B
    Risk Stratification and Intrinsic Subtype Classification of Breast Cancer: a Multi-Parameter Test to Rule Them All?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  47. BARTLETT JM, Bayani J, Marshall A, Dunn JA, et al
    Comparing Breast Cancer Multiparameter Tests in the OPTIMA Prelim Trial: No Test Is More Equal Than the Others.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    August 2016
  48. SEPEHRY AA, Tyldesley S, Davis MK, Simmons C, et al
    RE: Elucidating Pretreatment Cognitive Impairment in Breast Cancer Patients: The Impact of Cancer-Related Post-traumatic Stress.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  49. SIMON N, Antignani A, Sarnovsky R, Hewitt SM, et al
    Targeting a Cancer-Specific Epitope of the Epidermal Growth Factor Receptor in Triple-Negative Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  50. DEBEB BG, Lacerda L, Anfossi S, Diagaradjane P, et al
    miR-141-Mediated Regulation of Brain Metastasis From Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  51. SONNENBLICK A, de Azambuja E, Agbor-Tarh D, Bradbury I, et al
    Lapatinib-Related Rash and Breast Cancer Outcome in the ALTTO Phase III Randomized Trial.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  52. KWA M, Plottel CS, Blaser MJ, Adams S, et al
    The Intestinal Microbiome and Estrogen Receptor-Positive Female Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  53. MARTIN LJ, Huszti E, Connelly PW, Greenberg CV, et al
    RE: Serum Lipids, Lipoproteins, and Risk of Breast Cancer: A Nested Case-Control Study Using Multiple Time Points.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  54. TOOMEY S, Eustace AJ, Pritzker LB, Pritzker KP, et al
    RE: RNA Disruption Assay as a Biomarker of Pathological Complete Response in Neoadjuvant Trastuzumab-Treated Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  55. SCHMIDT C
    Mammaprint Reveals Who Can Skip Chemotherapy for Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    July 2016
  56. HODGSON DC, Cotton C, Crystal P, Nathan PC, et al
    Impact of Early Breast Cancer Screening on Mortality Among Young Survivors of Childhood Hodgkin's Lymphoma.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


    June 2016
  57. FILLON M
    Continuing To Smoke After Breast Cancer Diagnosis Lowers Survival Rate.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    May 2016
  58. DE GLAS NA, Kiderlen M, Vandenbroucke JP, de Craen AJ, et al
    Performing Survival Analyses in the Presence of Competing Risks: A Clinical Example in Older Breast Cancer Patients.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  59. ZHENG Z, Yabroff KR, Guy GP Jr, Han X, et al
    Annual Medical Expenditure and Productivity Loss Among Colorectal, Female Breast, and Prostate Cancer Survivors in the United States.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  60. ETZIONI R, Gulati R
    Active Surveillance for Ductal Carcinoma in Situ: Shining Light Into the Modeling Abyss.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  61. RYSER MD, Worni M, Turner EL, Marks JR, et al
    Outcomes of Active Surveillance for Ductal Carcinoma in Situ: A Computational Risk Analysis.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  62. COOPER GS, Kou TD, Schluchter MD, Dor A, et al
    Changes in Receipt of Cancer Screening in Medicare Beneficiaries Following the Affordable Care Act.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    April 2016
  63. ANDERSON GL, Barrington WE
    Narrowing of racial disparities in breast cancer incidence: insights from menopausal hormone therapy study findings.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  64. ROSENBERG L, Bethea TN, Viscidi E, Hong CC, et al
    Postmenopausal Female Hormone Use and Estrogen Receptor-Positive and -Negative Breast Cancer in African American Women.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  65. BERG WA, Bandos AI, Mendelson EB, Lehrer D, et al
    Ultrasound as the Primary Screening Test for Breast Cancer: Analysis From ACRIN 6666.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  66. WESTBROOK JA, Cairns DA, Peng J, Speirs V, et al
    CAPG and GIPC1: Breast Cancer Biomarkers for Bone Metastasis Development and Treatment.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  67. BRADSHAW PT, Nichols HB, Caan BJ
    RE: Weight Gain After Breast Cancer Diagnosis and All-Cause Mortality: Systematic Review and Meta-Analysis.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  68. PLAYDON MC, Bracken MB, Sanft TB, Ligibel JA, et al
    Response.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  69. AZVOLINSKY A
    Unraveling How Obesity Fuels Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  70. JENKS S
    Digital Imaging of the Breast: Is a Synthetic View Better?
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


    March 2016
  71. KROENKE CH, Chubak J, Johnson L, Castillo A, et al
    Enhancing Breast Cancer Recurrence Algorithms Through Selective Use of Medical Record Data.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  72. HAQUE R, Shi J, Schottinger JE, Ahmed SA, et al
    Tamoxifen and Antidepressant Drug Interaction in a Cohort of 16 887 Breast Cancer Survivors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  73. EVANS DG, Maxwell AJ
    MRI Screening in Women With a Personal History of Breast cancer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  74. SCHONBERG MA, Li VW, Eliassen AH, Davis RB, et al
    Performance of the Breast Cancer Risk Assessment Tool Among Women Age 75 Years and Older.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  75. LEHMAN CD, Lee JM, DeMartini WB, Hippe DS, et al
    Screening MRI in Women With a Personal History of Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format     Abstract available


  76. GOBBO J, Marcion G, Cordonnier M, Dias AM, et al
    Restoring Anticancer Immune Response by Targeting Tumor-Derived Exosomes With a HSP70 Peptide Aptamer.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  77. ETZIONI R, Gulati R
    Recognizing the Limitations of Cancer Overdiagnosis Studies: A First Step Towards Overcoming Them.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  78. SOHAL DP, Rini BI, Khorana AA, Dreicer R, et al
    Prospective Clinical Study of Precision Oncology in Solid Tumors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    February 2016
  79. MOCELLIN S, Pilati P, Briarava M, Nitti D, et al
    Breast Cancer Chemoprevention: A Network Meta-Analysis of Randomized Controlled Trials.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  80. FENICHEL M
    American Cancer Society Changes Breast Cancer Screening Guidelines To Reflect Analysis of Benefits and Harms.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  81. SINHA G
    Bovine Leukemia Virus Possibly Linked to Breast Cancer.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  82. MEEKS HD, Song H, Michailidou K, Bolla MK, et al
    BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  83. ASKOXYLAKIS V, Ferraro GB, Kodack DP, Badeaux M, et al
    Preclinical Efficacy of Ado-trastuzumab Emtansine in the Brain Microenvironment.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  84. KIM JJ, Tosteson AN, Zauber AG, Sprague BL, et al
    Cancer Models and Real-world Data: Better Together.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  85. TENG CJ, Hu YW, Chen SC, Yeh CM, et al
    Use of Radioactive Iodine for Thyroid Cancer and Risk of Second Primary Malignancy: A Nationwide Population-Based Study.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    January 2016
  86. JATOI I, Bandos H, Jeong JH, Anderson WF, et al
    Time-Varying Effects of Breast Cancer Adjuvant Systemic Therapy.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


  87. WION-BARBOT N, Wion D
    RE: Circulating Adipokines and Inflammatory Markers and Postmenopausal Breast Cancer Risk.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  88. KWAN ML, Quesenberry CP Jr, Caan BJ
    RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  89. LIGIBEL JA, Winer E, Hudis CA, Barry WT, et al
    Response.
    J Natl Cancer Inst. 2016;108.
    PubMed     Text format    


  90. SCHMIDT C
    Metastatic Cells Colonize Implantable Scaffold in Mice.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  91. ALFANO CM, Bluethmann SM, Tesauro G, Perna F, et al
    NCI Funding Trends and Priorities in Physical Activity and Energy Balance Research Among Cancer Survivors.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    December 2015
  92. MORROW M, Katz SJ
    Addressing Overtreatment in DCIS: What Should Physicians Do Now?
    J Natl Cancer Inst. 2015;107:djv290.
    PubMed     Text format    


  93. WORNI M, Akushevich I, Greenup R, Sarma D, et al
    Trends in Treatment Patterns and Outcomes for Ductal Carcinoma In Situ.
    J Natl Cancer Inst. 2015;107:djv263.
    PubMed     Text format     Abstract available


  94. DUNN BK, Steele VE, Fagerstrom RM, Topp CF, et al
    Predictive Value Tools as an Aid in Chemopreventive Agent Development.
    J Natl Cancer Inst. 2015;107:djv259.
    PubMed     Text format     Abstract available


    November 2015
  95. HUNG RJ, Ulrich CM, Goode EL, Brhane Y, et al
    Cross Cancer Genomic Investigation of Inflammation Pathway for Five Common Cancers: Lung, Ovary, Prostate, Breast, and Colorectal Cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  96. BARTH SD, Schulze JJ, Kuhn T, Raschke E, et al
    Treg-Mediated Immune Tolerance and the Risk of Solid Cancers: Findings From EPIC-Heidelberg.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  97. AN MW, Dong X, Meyers J, Han Y, et al
    Evaluating Continuous Tumor Measurement-Based Metrics as Phase II Endpoints for Predicting Overall Survival.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    October 2015
  98. ROCHMAN S
    Study Finds Black Women Have Denser Breast Tissue Than White Women.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  99. LLARENA NC, Estevez SL, Tucker SL, Jeruss JS, et al
    Impact of Fertility Concerns on Tamoxifen Initiation and Persistence.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


  100. PEAULT B
    Peril in perishing pericytes.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


  101. HONG J, Tobin NP, Rundqvist H, Li T, et al
    Role of Tumor Pericytes in the Recruitment of Myeloid-Derived Suppressor Cells.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format     Abstract available


    February 2015
  102. CHLEBOWSKI RT, Anderson GL, Aragaki AK, Prentice R, et al
    Breast Cancer and Menopausal Hormone Therapy by Race/Ethnicity and Body Mass Index.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format     Abstract available


    January 2015
  103. KWAN ML, Quesenberry CP Jr, Caan BJ
    RE: Body Mass Index, PAM50 Subtype, and Outcomes in Node-Positive Breast Cancer: CALGB 9741.
    J Natl Cancer Inst. 2015;108.
    PubMed     Text format    


  104. BIDARD FC
    Circulating Tumor Cells, a Tremendous Prognostic Factor in Inflammatory Breast Cancer.
    J Natl Cancer Inst. 2015;107.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Breast Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: